These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18580623)

  • 1. Peginterferon monotherapy for the treatment of acute hepatitis C in HIV-coinfected patients.
    Arends JE; Schrover IM; Schaar CG; Mudrikova T; Hoepelman AI
    AIDS; 2008 Jul; 22(11):1381-2. PubMed ID: 18580623
    [No Abstract]   [Full Text] [Related]  

  • 2. Pegylated interferon-alpha2a and ribavirin in HIV-hepatitis C coinfected patients.
    Expert Rev Anti Infect Ther; 2004 Jun; 2(3):341-2. PubMed ID: 15490503
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of hepatitis C in HIV-coinfected patients at the CROI.
    Barreiro P
    AIDS Rev; 2004; 6(1):63. PubMed ID: 15168743
    [No Abstract]   [Full Text] [Related]  

  • 4. [HIV/HCV coinfection: 40% of patients can successfully be treated].
    Dtsch Med Wochenschr; 2004 Apr; 129(16):911. PubMed ID: 15134089
    [No Abstract]   [Full Text] [Related]  

  • 5. Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?
    Bani-Sadr F; Denoeud L; Morand P; Lunel-Fabiani F; Pol S; Cacoub P; Perronne C; Carrat F;
    J Acquir Immune Defic Syndr; 2007 May; 45(1):123-5. PubMed ID: 17460476
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment with pegylated interferon and ribavirin in patients co-infected by human immunodeficiency virus and hepatitis C virus].
    Marcos Sánchez F; Albo Castaño MI; Casallo Blanco S
    Rev Clin Esp; 2007 Mar; 207(3):150-1; author reply 151-2. PubMed ID: 17397643
    [No Abstract]   [Full Text] [Related]  

  • 7. [HIV/HCV double infection: combination is a clear therapy option].
    Reich B
    Dtsch Med Wochenschr; 2004 Jul; 129(28-29):1590. PubMed ID: 15274242
    [No Abstract]   [Full Text] [Related]  

  • 8. Study results presented on interferon/ribavirin combination therapy.
    AIDS Read; 2001 Aug; 11(8):398. PubMed ID: 11570262
    [No Abstract]   [Full Text] [Related]  

  • 9. PegIFN/ribavirin during acute HCV coinfection.
    Bernard EJ
    IAPAC Mon; 2004 Jul; 10(7):260-1. PubMed ID: 15624247
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment with peginterferon and ribavirin in a patient with acute hepatitis C evolving into chronicity.
    Hsieh TH; Kao JH; Lai MY; Chen PJ; Chen DS
    J Formos Med Assoc; 2005 May; 104(5):354-8. PubMed ID: 15959603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCV infection in the setting of HIV: prevalence, disease, treatment.
    Laurence J
    AIDS Read; 2006 Mar; 16(3):115-6. PubMed ID: 16538952
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy and safety of combination therapy with interferon-alpha and ribavirin in patients with chronic hepatitis C coinfected with human immunodeficiency virus].
    Castéra L; Roulot D
    Gastroenterol Clin Biol; 2000 Oct; 24(10):978-9. PubMed ID: 11185920
    [No Abstract]   [Full Text] [Related]  

  • 13. Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.
    Ramos B; Núñez M; Rendón A; Berdún MA; Losada E; Santos I; Echevarría S; Ocampo A; Miralles C; Arazo P; Barreiro P; Romero M; Labarga P; Guardiola JM; Garcia-Samaniego J; Soriano V
    J Viral Hepat; 2007 Jun; 14(6):387-91. PubMed ID: 17501758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic histologic response (HR) to combination therapy among HCV/HIV-coinfected individuals: interferon induces HR independent of sustained virologic response (SVR).
    Wu L; Kottilil S; Lempicki R; Yang J; McLaughlin M; Hu Z; Koratich C; Reitano KN; Rehm CA; Masur H; Wood B; Kleiner DE; Polis MA
    AIDS Res Hum Retroviruses; 2006 Nov; 22(11):1091-8. PubMed ID: 17147494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
    Carrat F; Bani-Sadr F; Pol S; Rosenthal E; Lunel-Fabiani F; Benzekri A; Morand P; Goujard C; Pialoux G; Piroth L; Salmon-Céron D; Degott C; Cacoub P; Perronne C;
    JAMA; 2004 Dec; 292(23):2839-48. PubMed ID: 15598915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primer treatment of acute and chronic hepatitis C].
    Daruich J; Fainboim H; Frider B
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S52-6; discussion S74-82. PubMed ID: 16862862
    [No Abstract]   [Full Text] [Related]  

  • 17. Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
    Taylor LE; Rich JD; Tashima KT
    N Engl J Med; 2004 Nov; 351(22):2340-2; author reply 2340-2. PubMed ID: 15564553
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment algorithm for the management of hepatitis C in HIV-coinfected persons.
    Sulkowski MS
    J Hepatol; 2006; 44(1 Suppl):S49-55. PubMed ID: 16360232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and hepatitis C virus coinfection: bad bedfellows.
    Schooley RT
    Top HIV Med; 2005; 13(4):112-6. PubMed ID: 16304454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peginterferon plus ribavirin for hepatitis C in HIV-infected patients.
    Gholam PM
    N Engl J Med; 2004 Nov; 351(22):2340-2; author reply 2340-2. PubMed ID: 15570682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.